CN115927674A - CDA primer group and kit for detecting staphylococcus aureus and application of CDA primer group and kit - Google Patents
CDA primer group and kit for detecting staphylococcus aureus and application of CDA primer group and kit Download PDFInfo
- Publication number
- CN115927674A CN115927674A CN202210969466.7A CN202210969466A CN115927674A CN 115927674 A CN115927674 A CN 115927674A CN 202210969466 A CN202210969466 A CN 202210969466A CN 115927674 A CN115927674 A CN 115927674A
- Authority
- CN
- China
- Prior art keywords
- staphylococcus aureus
- sau
- cda
- kit
- primer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000191967 Staphylococcus aureus Species 0.000 title claims abstract description 54
- 238000001514 detection method Methods 0.000 claims abstract description 22
- 239000002773 nucleotide Substances 0.000 claims abstract description 5
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 5
- 238000006243 chemical reaction Methods 0.000 claims description 33
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 25
- 230000003321 amplification Effects 0.000 claims description 24
- 150000007523 nucleic acids Chemical class 0.000 claims description 21
- 108020004707 nucleic acids Proteins 0.000 claims description 20
- 102000039446 nucleic acids Human genes 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 12
- AUIINJJXRXMPGT-UHFFFAOYSA-K trisodium 3-hydroxy-4-[(2-hydroxy-4-sulfonatonaphthalen-1-yl)diazenyl]naphthalene-2,7-disulfonate Chemical compound [Na+].[Na+].[Na+].Oc1cc(c2ccccc2c1N=Nc1c(O)c(cc2cc(ccc12)S([O-])(=O)=O)S([O-])(=O)=O)S([O-])(=O)=O AUIINJJXRXMPGT-UHFFFAOYSA-K 0.000 claims description 11
- 238000012360 testing method Methods 0.000 claims description 10
- 238000003745 diagnosis Methods 0.000 claims description 8
- 201000010099 disease Diseases 0.000 claims description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 8
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 6
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 6
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 6
- 229960003237 betaine Drugs 0.000 claims description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 4
- 239000011535 reaction buffer Substances 0.000 claims description 4
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 4
- 239000012498 ultrapure water Substances 0.000 claims description 4
- CGNLCCVKSWNSDG-UHFFFAOYSA-N SYBR Green I Chemical compound CN(C)CCCN(CCC)C1=CC(C=C2N(C3=CC=CC=C3S2)C)=C2C=CC=CC2=[N+]1C1=CC=CC=C1 CGNLCCVKSWNSDG-UHFFFAOYSA-N 0.000 claims description 3
- 238000011161 development Methods 0.000 claims description 3
- 239000007810 chemical reaction solvent Substances 0.000 claims description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 2
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- AMMWFYKTZVIRFN-UHFFFAOYSA-N sodium 3-hydroxy-4-[(1-hydroxynaphthalen-2-yl)diazenyl]-7-nitronaphthalene-1-sulfonic acid Chemical compound [Na+].C1=CC=CC2=C(O)C(N=NC3=C4C=CC(=CC4=C(C=C3O)S(O)(=O)=O)[N+]([O-])=O)=CC=C21 AMMWFYKTZVIRFN-UHFFFAOYSA-N 0.000 claims description 2
- 229920002113 octoxynol Polymers 0.000 claims 1
- 239000012634 fragment Substances 0.000 abstract description 3
- 230000035945 sensitivity Effects 0.000 abstract description 3
- 230000000007 visual effect Effects 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 10
- 230000035484 reaction time Effects 0.000 description 9
- 229920004890 Triton X-100 Polymers 0.000 description 5
- 239000013504 Triton X-100 Substances 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000053602 DNA Human genes 0.000 description 4
- 206010016952 Food poisoning Diseases 0.000 description 4
- 208000019331 Foodborne disease Diseases 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 241000186781 Listeria Species 0.000 description 3
- 241000607142 Salmonella Species 0.000 description 3
- 241000607768 Shigella Species 0.000 description 3
- 241000607272 Vibrio parahaemolyticus Species 0.000 description 3
- 229960000484 ceftazidime Drugs 0.000 description 3
- NMVPEQXCMGEDNH-TZVUEUGBSA-N ceftazidime pentahydrate Chemical compound O.O.O.O.O.S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC(C)(C)C(O)=O)C=2N=C(N)SC=2)CC=1C[N+]1=CC=CC=C1 NMVPEQXCMGEDNH-TZVUEUGBSA-N 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 238000003908 quality control method Methods 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001917 fluorescence detection Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 101710146739 Enterotoxin Proteins 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000147 enterotoxin Substances 0.000 description 1
- 231100000655 enterotoxin Toxicity 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000011901 isothermal amplification Methods 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 229910001437 manganese ion Inorganic materials 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 235000012736 patent blue V Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000015339 staphylococcus aureus infection Diseases 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
技术领域technical field
本发明属于生物检测技术领域,具体涉及一种检测金黄色葡萄球菌的CDA引物组、试剂盒及其应用。The invention belongs to the technical field of biological detection, and in particular relates to a CDA primer set, a kit and an application thereof for detecting Staphylococcus aureus.
背景技术Background technique
金黄色葡萄球菌(Staphylococcus aureus,SAU)为一种常见的食源性致病微生物,广泛存在于自然环境中。金黄色葡萄球菌在适当的条件下,能够产生肠毒素,引起食物中毒。金黄色葡萄球菌引发的食物中毒报道层出不穷,由金黄色葡萄球菌引起的食物中毒占食源性微生物食物中毒事件的25%左右,金黄色葡萄球菌成为仅次于沙门氏菌和副溶血杆菌的第三大微生物致病菌。Staphylococcus aureus (SAU) is a common food-borne pathogenic microorganism that widely exists in the natural environment. Staphylococcus aureus can produce enterotoxin and cause food poisoning under appropriate conditions. Reports of food poisoning caused by Staphylococcus aureus emerge in endlessly. Food poisoning caused by Staphylococcus aureus accounts for about 25% of food-borne microbial food poisoning incidents. Microbial pathogens.
金黄色葡萄球菌的经典检测方法为分离培养,具体为:将经中和集菌材料接种于固体培养基,器皿口加橡皮塞于37℃培养,每周观察1次。但金黄色葡萄球菌生长缓慢,一般需2~4周长成肉眼可见的落菌。其他较为快速和准确的方法,包括基于RT-PCR的针对金黄色葡萄球菌DNA的扩增信号的检测,每毫升中只需含几个细菌即可检测到阳性,且1-2天即得出结果。但RT-PCR方法需要在标准生化分析实验室,使用精密的实时荧光PCR仪,并需要试剂准备、标本制备和PCR扩增检测三个独立的试验区,并不适用于现场快速筛查。此外,免疫检测技术所制成的试纸条具有简便快捷的优势,但该方法误检率高、灵敏度低,难于检测处于潜伏期的SAU携带者,可能造成疫情的扩散。因此,快速、灵敏、高特异性核酸标志物现场检测技术的研发,将对由金黄色葡萄球菌感染所导致的疾病提供快速有力的治疗手段。The classic detection method of Staphylococcus aureus is isolation and culture, specifically: inoculate the neutralized bacteria-collecting material on solid medium, culture at 37°C with a rubber stopper on the mouth of the vessel, and observe once a week. However, Staphylococcus aureus grows slowly, and generally takes 2 to 4 weeks to grow into colonies visible to the naked eye. Other relatively rapid and accurate methods, including RT-PCR-based detection of the amplification signal of Staphylococcus aureus DNA, only need to contain a few bacteria per milliliter to detect positive results, and the results can be obtained within 1-2 days result. However, the RT-PCR method requires the use of a sophisticated real-time fluorescent PCR instrument in a standard biochemical analysis laboratory, and requires three separate test areas for reagent preparation, specimen preparation, and PCR amplification detection, and is not suitable for on-site rapid screening. In addition, the test strips made by immunoassay technology have the advantage of being simple and quick, but this method has a high false detection rate and low sensitivity, making it difficult to detect SAU carriers in the incubation period, which may cause the spread of the epidemic. Therefore, the development of rapid, sensitive, and highly specific nucleic acid marker on-site detection technology will provide a rapid and powerful treatment for diseases caused by Staphylococcus aureus infection.
基于闭合颈环介导的核酸恒温扩增技术(Closed Dumbbell mediatedIsothermal Amplification of nucleic acids,CDA)是由中国科学院大学宁波生命与健康产业研究院开发的新方法(中国专利号:ZL202110473121.8),可替代日本LAMP核酸扩增方法。该方法主要利用2种不同的特异性引物识别靶基因的特定区域,在等温条件进行扩增反应。与常规基因检测手段(如PCR等)相比,CDA反应在恒温水浴箱内便可完成,对仪器设备的要求较低,且操作简单,非专业人士也可准确地完成,适合于基层医疗机构及地方检验检疫部门。并且,CDA还可以缩短操作时间,提高检测效率,降低样品污染的机率,适用于金黄色葡萄球菌的快速诊断。此外,CDA所用关键成环引物约为30bp,较LAMP(40bp)短,这将节省检测成本。Closed Dumbbell mediated Isothermal Amplification of nucleic acids (CDA) is a new method developed by Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences (China Patent No.: ZL202110473121.8), which can An alternative to the Japanese LAMP nucleic acid amplification method. This method mainly uses two different specific primers to identify specific regions of the target gene, and performs amplification reactions under isothermal conditions. Compared with conventional genetic detection methods (such as PCR, etc.), the CDA reaction can be completed in a constant temperature water bath, which requires less equipment and is easy to operate. It can also be completed accurately by non-professionals. It is suitable for primary medical institutions and local inspection and quarantine departments. Moreover, CDA can also shorten the operation time, improve the detection efficiency, and reduce the probability of sample contamination, which is suitable for the rapid diagnosis of Staphylococcus aureus. In addition, the key looping primer used by CDA is about 30bp, which is shorter than that of LAMP (40bp), which will save the detection cost.
发明内容Contents of the invention
本发明的目的是,提供一种检测金黄色葡萄球菌的CDA引物组、试剂盒及其应用。The purpose of the present invention is to provide a CDA primer set, kit and application for detecting Staphylococcus aureus.
本发明为实现上述目的所采用的技术方案如下:The technical scheme that the present invention adopts for realizing the above object is as follows:
本发明通过对表1所述的4对引物组进行筛选,获得对金黄色葡萄球菌检测效果最优的引物组为SAU-MF-3/SAU-MR-3。In the present invention, by screening the 4 pairs of primer sets described in Table 1, the primer set with the best detection effect on Staphylococcus aureus is SAU-MF-3/SAU-MR-3.
表1Table 1
本发明还提供一种检测金黄色葡萄球菌的试剂盒,所述试剂盒包括CDA引物组SAU-MF-3/SAU-MR-3。The present invention also provides a kit for detecting Staphylococcus aureus, which includes a CDA primer set SAU-MF-3/SAU-MR-3.
作为优选实施方案,所述CDA引物组中的引物SAU-MF和SAU-MR在反应体系中的浓度均为1~2μM。As a preferred embodiment, the concentrations of the primers SAU-MF and SAU-MR in the CDA primer set in the reaction system are both 1-2 μM.
作为优选实施方案,所述试剂盒还包括Bst聚合酶、CDA反应缓冲液、超纯水、以及显色剂。As a preferred embodiment, the kit also includes Bst polymerase, CDA reaction buffer, ultrapure water, and chromogen.
作为优选实施方案,所述显色剂选自Sybr green I、Eva green、羟基萘酚蓝或铬黑T。As a preferred embodiment, the color developer is selected from Sybr green I, Eva green, hydroxynaphthol blue or chrome black T.
作为优选实施方案,所述CDA反应缓冲液包括Tris-HCl、KCl、(NH4)2SO4、MgSO4和Triton X-100。As a preferred embodiment, the CDA reaction buffer includes Tris-HCl, KCl, (NH 4 ) 2 SO 4 , MgSO 4 and Triton X-100.
作为优选实施方案,所述试剂盒反应体系的组成为:As a preferred embodiment, the composition of the kit reaction system is:
2~50mM Tris-HClpH8.82~50mM Tris-HClpH8.8
2~20mM KCl2~20mM KCl
2~20mM(NH4)2SO4 2~20mM(NH 4 ) 2 SO 4
2~20mM MgSO4 2~20mM MgSO4
0.1~0.5%TritonX-1000.1~0.5%TritonX-100
0.2~1M甜菜碱0.2~1M betaine
1~1.6mM dNTP1~1.6mM dNTP
5~10U Bst DNA聚合酶5~10U Bst DNA polymerase
100~150μmol/L显色剂100~150μmol/L developer
1~2μM引物SAU-MF-31~2μM Primer SAU-MF-3
1~2μM引物SAU-MR-31~2μM Primer SAU-MR-3
反应溶剂为超纯水。The reaction solvent is ultrapure water.
本发明还提供该试剂盒用于非疾病诊断目的的检测金黄色葡萄球菌的方法,包括以下步骤:The present invention also provides the method for detecting Staphylococcus aureus that the kit is used for non-disease diagnosis purpose, comprising the following steps:
步骤1,将待检测核酸样本和试剂盒的反应体系混合,制得扩增反应液;Step 1, mixing the nucleic acid sample to be detected with the reaction system of the kit to prepare an amplification reaction solution;
步骤2,将步骤1所得扩增反应液,于60~65℃反应20~80min,根据显色结果判断样品是否含有金黄色葡萄球菌。Step 2: react the amplification reaction solution obtained in step 1 at 60-65° C. for 20-80 minutes, and judge whether the sample contains Staphylococcus aureus according to the color development result.
本发明还提供所述的CDA引物组在以非疾病诊断为目的的金黄色葡萄球菌检测中的应用。The present invention also provides the application of the CDA primer set in the detection of Staphylococcus aureus for the purpose of non-disease diagnosis.
本发明还提供上述试剂盒在以非疾病诊断为目的的金黄色葡萄球菌检测中的应用。The present invention also provides the application of the above kit in the detection of Staphylococcus aureus for the purpose of non-disease diagnosis.
与现有技术相比,本发明的有益效果为:Compared with prior art, the beneficial effect of the present invention is:
1,本发明提供的CDA引物组针对金黄色葡萄球菌的特异保守区域Staphylococcusaureus strain 332chromosome(GenBank:CP077893.1),由2条引物组成,为序列内引物对(SAU-MF-3/SAU-MR-3)。本发明提供的引物组敏感性高、特异性强,由其制成的试剂盒能够快速、准确的检测到待测样品中是否含有金黄色葡萄球菌。1. The CDA primer set provided by the present invention is directed at the specific conserved region Staphylococcusaureus strain 332chromosome (GenBank: CP077893.1) of Staphylococcus aureus, and consists of 2 primers, which are primer pairs within the sequence (SAU-MF-3/SAU-MR -3). The primer set provided by the invention has high sensitivity and strong specificity, and the kit made from it can quickly and accurately detect whether the sample to be tested contains Staphylococcus aureus.
2,由于本发明提供的引物组具有极高的特异性,CDA扩增所需时间短,进一步缩短了检测时间,且操作简易。2. Since the primer set provided by the present invention has extremely high specificity, the time required for CDA amplification is short, the detection time is further shortened, and the operation is simple.
3,本发明提供的方法或试剂盒无需昂贵的仪器、也无需复杂的操作就可完成相关检测,因此,本发明所提供的可视化试剂盒将为专业性不高的机场、海关、社区等地的现场检测提供极大便利,可实现对金黄色葡萄球菌快速准确的检测。3. The method or kit provided by the present invention can complete the relevant detection without expensive instruments and complicated operations. Therefore, the visualization kit provided by the present invention will be used in airports, customs, communities and other places with low professionalism. It provides great convenience for on-site detection and can realize rapid and accurate detection of Staphylococcus aureus.
附图说明Description of drawings
图1为本发明实施例1中四对引物组扩增反应的荧光强度随反应时间变化的曲线图。Fig. 1 is a graph showing the variation of the fluorescence intensity of the amplification reaction of the four pairs of primer sets as a function of the reaction time in Example 1 of the present invention.
图2为本发明实施例2中第3组引物扩增反应的荧光强度随反应时间变化的曲线图。Fig. 2 is a graph showing the fluorescence intensity of the amplification reaction of the third group of primers as a function of reaction time in Example 2 of the present invention.
图3为本发明实施例3中第3组引物扩增反应的荧光强度随反应时间变化的曲线图。Fig. 3 is a graph showing the fluorescence intensity of the amplification reaction of the third group of primers as a function of reaction time in Example 3 of the present invention.
图4为本发明实施例4中应用HNB进行反应基于颜色变化的终点监测图。Fig. 4 is an end point monitoring diagram based on color change in the reaction using HNB in Example 4 of the present invention.
具体实施方式Detailed ways
下面结合实施例对本发明的技术方案进行详细说明。下述实施例中所使用的实验方法如无特殊说明,均为常规方法,可参照《分子克隆实验指南》(第三版)J.萨姆布鲁克一书中的具体方法进行,或者按照试剂盒和产品说明书进行。下述实施例中所用的材料、试剂等,如无特殊说明,均可从商业途径得到。The technical solution of the present invention will be described in detail below in conjunction with the embodiments. Unless otherwise specified, the experimental methods used in the following examples are conventional methods, and can be carried out with reference to the specific methods in the book "Molecular Cloning Experiment Guide" (Third Edition) J. Sambrook, or according to the kit and product manual. The materials and reagents used in the following examples can be obtained from commercial sources unless otherwise specified.
实施例1应用Eva Green分别验证四对引物组对金黄色葡萄球菌基因DNA片段的扩增反应Embodiment 1 uses Eva Green to verify respectively the amplification reaction of four pairs of primer sets to Staphylococcus aureus gene DNA fragment
Eva Green同SYBR Green I类似,是一种结合于所有dsDNA双螺旋小沟区域的具有绿色激发波长的染料,其对PCR等核酸扩增反应的抑制远小于后者。Eva Green的荧光信号强度与双链DNA的数量相关。在游离状态下,Eva Green发出微弱的荧光,但与双链DNA结合后,其荧光大大增强。因此,可以根据荧光信号检测出核酸扩增体系存在的双链DNA数量。Similar to SYBR Green I, Eva Green is a dye with a green excitation wavelength that binds to the minor groove region of all dsDNA double helices, and its inhibition on nucleic acid amplification reactions such as PCR is much smaller than that of the latter. The fluorescence signal intensity of Eva Green correlates with the amount of double-stranded DNA. In the free state, Eva Green emits weak fluorescence, but when combined with double-stranded DNA, its fluorescence is greatly enhanced. Therefore, the amount of double-stranded DNA present in the nucleic acid amplification system can be detected based on the fluorescent signal.
单管反应溶液组合如下(其余加入ddH2O至25μL):The single-tube reaction solution was combined as follows (add ddH 2 O to 25 μL for the rest):
20mM Tris-HCl pH8.820mM Tris-HCl pH8.8
10mM KCl10mM KCl
10mM(NH4)2SO4 10mM(NH 4 ) 2 SO 4
14mM MgSO4 14mM MgSO 4
0.1%Triton X-1000.1% Triton X-100
1M甜菜碱1M betaine
1.25mM dNTP1.25mM dNTPs
8U Bst DNA聚合酶(NEW ENGLAND Biolabs)8U Bst DNA Polymerase (NEW ENGLAND Biolabs)
1X Eva Green(Biotum)1X Eva Green(Biotum)
单管使用引物:Primers used in a single tube:
1600nM SAU-MF-1(SEQ ID NO.1所示)1600nM SAU-MF-1 (shown in SEQ ID NO.1)
1600nM SAU-MR-1(SEQ ID NO.2所示);1600nM SAU-MR-1 (shown in SEQ ID NO.2);
1600nM SAU-MF-2(SEQ ID NO.3所示)1600nM SAU-MF-2 (shown in SEQ ID NO.3)
1600nM SAU-MR-2(SEQ ID NO.4所示);1600nM SAU-MR-2 (shown in SEQ ID NO.4);
1600nM SAU-MF-3(SEQ ID NO.5所示)1600nM SAU-MF-3 (shown in SEQ ID NO.5)
1600nM SAU-MR-3(SEQ ID NO.6所示);1600nM SAU-MR-3 (shown in SEQ ID NO.6);
1600nM SAU-MF-4(SEQ ID NO.7所示)1600nM SAU-MF-4 (shown in SEQ ID NO.7)
1600nM SAU-MR-4(SEQ ID NO.8所示)。1600nM SAU-MR-4 (shown in SEQ ID NO.8).
靶:金黄色葡萄球菌基因组DNA dsDNA(SEQ ID NO.9所示)。Target: Staphylococcus aureus genomic DNA dsDNA (shown in SEQ ID NO.9).
SEQ ID NO.9:SEQ ID NO.9:
ctgacgtatcttccataaatgatctaaaaattggtagttcttcttcagataaaaatcttactttaacaccattctttttaacttttttcgtgtttctttttctaagtccatccatatttttaatgatgtcatctgctgttttatcttttaaatctaacactgagtgataacgaatttgtagcacaggatcaaatcctttatggaatccagtatgttcaaatcctaagttactcattttatcaaagaaccaatcattaccagcattacctgtaatctcgccatcatgattcaagtattgatatggtaaatatggatcgatatgtaggtatagacaacgatgttttttaacatattttgataattcattaaagaaaaagtgtacgagttcttgattttcataatcaatcactggaccgcgatttgaataaaaatacttgaacactttcataacaggtacagcagtaagtaagcaagctgcaatgacctcgttattattgttttttattcccactaaatgtgtttcataaccttcagcaagctttaactcatagtggccaacagtttgcgtgaaatgactgtatggcatgctatctgtaaaggcaccaaactctttagctgttaaatttgtaaacttcattatcattactcctatttgtctctcgttaattaatttcatttccgtatttgcagtttttctatttcccctctgcaaatgtcaaaaataataaatctaatctaaataagtatacaatagttaatgttaaaactaaaacataaacgctttaattgcgtatacttttatagtaatatttagatttttgaatacaatttcaaaaaaagtaatatgaacgtttgggtttgctcatattacttttgtatcatttctattcaattttataattcaccgtttttcactttttcaaacagtattcgcctaatttttttaaatcaagtaaacttaattattcaatgtttgttggatagattgtaaatatttaatgatttcctcacgcgtgttagatttaaatcgcttaacgatttcgctaccaatgacaatgccatctgcaacctcttttatatctgcaacatgttgtggtgttcttataccaaatcctgcgacaactggcacattggctatcgctttaattgactcaatttttcgttttaattctggatgaaacgcaccgttttgccctgttgtcgcattcatcgtcacagtataaataaagccttccgcatgggatacgatatcttttatacgtttgtcatcagtagtcatcgcaactaacgatatgattttgacgccatagtgactaaattgttgttttaaacgctgcgataattcatatggtaaatcaggaataattaagccgtagacaccagtatctcgacatttttcaaaaaacgcttgttctccataatgacaaataatattataatacgtcattaatacatagttacacttaatttgatcaccatgtttttctaattgattgaaaatataatctatcgtgatgccttgtttaatcgcttgttgacctgcttccatgataactggaccatcagcaaccggatcagagaaaggtactccaatttcaattatatctgcaccattttcactcaacaatgttgcattttcaatcaaatctttattgcccataatataaggtataaataatttagtcatttgcaagacctcgctctaccatatattgtctaattgtttccatatctttatcgccacgtccagaaatagttactacaataatatcttctttcgacatcgtaggcgctagtctttcaacataactcagtgcatgtgcactttcaattgcaggtataataccttcatgttttgtaaagttgattaaagcattcattgcttgtgtatcactagcattttcaaaagttactctaccaatgtcgtggtaataagaatgttctggtccaataccaggataatcaagtccctgacgtatcttccataaatgatctaaaaattggtagttcttcttcagataaaaatcttactttaacaccattctttttaactttttcgtgtttctttttctaagtccatccatatttttaatgatgtcatctgctgttttcttttaaatctaacactgagtgataacgaatttgtagcacaggat caaatcctttatggaatccagtatgttcaaatcctaagttatcatttttcaaagaaccaatcattaccagcattacctgtaatctcgccatcatgattcaagtattgatatggtaaatatggatcgatatgtaggtatagacaacgatgttttttaacatattttgataattcattaaagaaaaagtgtacgagttcttgattt tcataatcaatcactggaccgcgatttgaataaaaatacttgaacactttcataacaggtacagcagtaagtaagcaagctgcaatgacctcgttattattgttttttattccactaaatgtttcataaccttcagcaagctttaactcatagtggccaacagtttgcgtgaaatgactgtatggcatgctatctgtaa aggcaccaaactctttagctgttaaatttgtaaacttcattatcattactcctatttgtctctcgttaattaatttcattccgtatttgcagtttttctatttcccctctgcaaatgtcaaaaataataaatctaatctaaataagtatacaatagttaatgttaaaactaaaacataaacgctttaattgcgtatactt ttatagtaatatttagatttttgaatacaatttcaaaaaaagtaatatgaacgtttgggtttgctcatattacttttgtatcatttctattcaattttataattcaccgtttttcactttttcaaacagtattcgcctaatttttttaaatcaagtaaacttaattattcaatgtttgttggatagattgtaaatatttaatgatt tcctcacgcgtgttagatttaaatcgcttaacgatttcgctaccaatgacaatgccatctgcaacctcttttatctgcaacatgttgtggtgttcttataccaaatcctgcgacaactggcacattggctatcgctttaattgactcaatttttcgttttaattctggatgaaacgcaccgttttgccctgt tgtcgcattcatcgtcacagtataaataaagccttccgcatgggaatacgatatcttttatacgtttgtcatcagtagtcatcgcaactaacgatatgattttgacgccatagtgactaaattgttgttttaaacgctgcgataattcatatggtaaatcaggaataattaagccgtagacaccagtatctcgacatttt tcaaaaaacgcttgttctccataatgacaaataatattataatacgtcattaatacatagttacacttaatttgatcaccatgtttttctaattgattgaaaatataatctatcgtgatgccttgtttaatcgcttgttgacctgcttccatgataactggaccatcagcaaccggatcagagaaaggtactccaatttcaattatatct gcaccattttcactcaacaatgttgcattttcaatcaaatctttatgcccataatataaggtataaataatttagtcatttgcaagacctcgctctaccatatattgtctaattgtttccatatctttatcgccacgtccagaaatagttactacaataatcttctttcgacatcgtaggcgctagtctttcaacataactcag tgcatgtgcactttcaattgcaggtataataccttcatgttttgtaaagttgattaaagcattcattgcttgtgtatcactagcattttcaaaagttactctaccaatgtcgtggtaataagaatgttctggtccaataccaggataatcaagtcc
同时四对引物组分别设置无靶的对照组。At the same time, the four pairs of primer groups were respectively set up as control groups without targets.
设置SLAN 96real time PCR反应温度恒定为63℃,反应时间为60min。检测结果如图1,通过图1可以发现:仅有两组引物组的阳性组出现扩增,第2组扩增速率不高,第3组引物组出现扩增Ct值最快。结果表明:本发明提供的第3组引物组可实现对金黄色葡萄球菌基因的快速扩增,且阴性对照组无假阳性出现,将荧光检测应用于其中可进行实时监测,通过实时扩增曲线可提前判断结果。Set the SLAN 96 real time PCR reaction temperature to be constant at 63°C, and the reaction time to be 60min. The detection results are shown in Figure 1. From Figure 1, it can be found that only the positive groups of the two primer sets were amplified, the amplification rate of the second set was not high, and the amplification Ct value of the third set of primer sets was the fastest. The result shows: the 3rd group of primer sets provided by the present invention can realize the fast amplification to Staphylococcus aureus gene, and negative control group does not have false positive to occur, and fluorescence detection is applied wherein can carry out real-time monitoring, through real-time amplification curve The results can be judged in advance.
实施例2应用Eva Green验证第3组引物组对金黄色葡萄球菌基因DNA片段的扩增反应(重复实验)Embodiment 2 uses Eva Green to verify the amplification reaction of the 3rd group of primer sets to Staphylococcus aureus gene DNA fragment (repeat experiment)
方法同实施例1。Method is with embodiment 1.
单管反应溶液组合如下(其余加入ddH2O至25μL):The single-tube reaction solution was combined as follows (add ddH 2 O to 25 μL for the rest):
20mM Tris-HCl pH8.820mM Tris-HCl pH8.8
10mM KCl10mM KCl
10mM(NH4)2SO4 10mM(NH 4 ) 2 SO 4
14mM MgSO4 14mM MgSO 4
0.1%Triton X-1000.1% Triton X-100
1M甜菜碱1M Betaine
1.25mM dNTP1.25mM dNTPs
8U Bst DNA聚合酶(NEW ENGLAND Biolabs)8U Bst DNA Polymerase (NEW ENGLAND Biolabs)
1X Eva Green(Biotum)1X Eva Green(Biotum)
单管使用引物:Primers used in a single tube:
1600nM SAU-MF-3(SEQ ID NO.5所示)1600nM SAU-MF-3 (shown in SEQ ID NO.5)
1600nM SAU-MR-3(SEQ ID NO.6所示);1600nM SAU-MR-3 (shown in SEQ ID NO.6);
同时设置有靶和无靶的对照组各8组,反应溶液组合同实施例1。靶:金黄色葡萄球菌基因组DNA dsDNA(SEQ ID NO.9所示)。Simultaneously, 8 control groups with targets and without targets were set up, and the reaction solution combinations were the same as in Example 1. Target: Staphylococcus aureus genomic DNA dsDNA (shown in SEQ ID NO.9).
设置SLAN 96real time PCR反应温度恒定为63℃,反应时间为60min。对引物组3进行8个阴性的重复实验,无假阳性出现,重复性较好,并进行8个阳性样本的对照实验,其荧光强度随反应时间变化的曲线如图2所示。图2结果表明:本发明提供的第3组引物组可实现对金黄色葡萄球菌基因的准确检测,荧光检测可实现实时监测,通过实时扩增曲线可提前判断结果。Set the SLAN 96 real time PCR reaction temperature to be constant at 63°C, and the reaction time to be 60min. 8 negative repeated experiments were carried out on primer group 3, no false positives occurred, and the repeatability was good, and a control experiment of 8 positive samples was carried out. The curve of the fluorescence intensity changing with the reaction time is shown in Figure 2. The results in Fig. 2 show that: the third set of primers provided by the present invention can realize the accurate detection of Staphylococcus aureus gene, the fluorescence detection can realize real-time monitoring, and the result can be judged in advance through the real-time amplification curve.
实施例3应用Eva Green验证第3组引物组对多种细菌提取基因组的扩增反应Example 3 Application of Eva Green to verify the amplification reaction of the third group of primer sets to the extraction genome of various bacteria
方法同实施例1。Method is with embodiment 1.
反应溶液组合如下(其余加入ddH2O至25μL):The reaction solution was combined as follows (add ddH 2 O to 25 μL for the rest):
20mM Tris-HCl pH8.820mM Tris-HCl pH8.8
10mM KCl10mM KCl
10mM(NH4)2SO4 10mM(NH 4 ) 2 SO 4
14mM MgSO4 14mM MgSO 4
0.1%Triton X-1000.1% Triton X-100
1M甜菜碱1M betaine
1.25mM dNTP1.25mM dNTPs
8U Bst DNA聚合酶(NEW ENGLAND Biolabs)8U Bst DNA Polymerase (NEW ENGLAND Biolabs)
1X Eva Green(Biotum)1X Eva Green(Biotum)
第3组引物:Group 3 primers:
1600nM SAU-MF-3(SEQ ID NO.5所示)1600nM SAU-MF-3 (shown in SEQ ID NO.5)
1600nM SAU-MR-3(SEQ ID NO.6所示)1600nM SAU-MR-3 (shown in SEQ ID NO.6)
靶核酸1:金黄色葡萄球菌阳性质控Target nucleic acid 1: Staphylococcus aureus positive quality control
靶核酸2:金黄色葡萄球菌基因组Target Nucleic Acid 2: Genome of Staphylococcus aureus
靶核酸3:志贺氏菌基因组Target nucleic acid 3: Shigella genome
靶核酸4:大肠杆菌基因组Target nucleic acid 4: Escherichia coli genome
靶核酸5:沙门氏菌基因组Target nucleic acid 5: Salmonella genome
靶核酸6:李斯特氏菌基因组Target nucleic acid 6: Listeria genome
靶核酸7:副溶血弧菌基因组Target nucleic acid 7: Vibrio parahaemolyticus genome
同时设置无靶的对照组,作为阴性对照。At the same time, a target-free control group was set up as a negative control.
每组扩增反应设置8个重复试验。设置SLAN 96real time PCR反应温度恒定为63℃,反应时间为60min。荧光强度随反应时间变化的曲线如图3所示。图3结果表明:本发明提供的第3组引物组仅能扩增出阳性样本组金黄色葡萄球菌阳性质控和金黄色葡萄球菌基因组DNA,对于其他细菌均无法扩增出;因此该引物组能够区分金黄色葡萄球菌和志贺氏菌、大肠杆菌基因组、沙门氏菌基因组、李斯特氏菌基因组、副溶血弧菌基因组。实验结果进一步说明了本发明提供的检测金黄色葡萄球菌的CDA引物组的特异性。Eight replicates were set up for each set of amplification reactions. Set the SLAN 96 real time PCR reaction temperature to be constant at 63°C, and the reaction time to be 60min. The curve of the fluorescence intensity changing with the reaction time is shown in Fig. 3 . Fig. 3 result shows: the 3rd group of primer sets provided by the present invention can only amplify positive sample group Staphylococcus aureus positive quality control and Staphylococcus aureus genomic DNA, all can't amplify for other bacteria; Therefore this primer set Able to distinguish Staphylococcus aureus from Shigella, Escherichia coli genome, Salmonella genome, Listeria genome, Vibrio parahaemolyticus genome. The experimental results further illustrate the specificity of the CDA primer set provided by the present invention for detecting Staphylococcus aureus.
实施例4应用羟基萘酚兰(HNB)进行金黄色葡萄球菌CDA扩增反应终点监测Example 4 Application of hydroxynaphthol blue (HNB) to monitor the end point of Staphylococcus aureus CDA amplification reaction
羟基萘酚兰(HNB)属于金属离子指示剂,是针对反应中与副产物焦磷酸盐结合的镁离子或者锰离子量的变化,从而呈现不同指示颜色以实现对结果的判断。Hydroxynaphthol blue (HNB) is a metal ion indicator, which is aimed at the change of the amount of magnesium ions or manganese ions combined with the by-product pyrophosphate during the reaction, so as to present different indicator colors to realize the judgment of the result.
应用羟基萘酚兰(HNB)进行金黄色葡萄球菌CDA扩增的反应溶液的组合如下所示。Combinations of reaction solutions for CDA amplification of Staphylococcus aureus using hydroxynaphthol blue (HNB) are shown below.
反应溶液组合如下(其余加入ddH2O至25μL):The reaction solution was combined as follows (add ddH 2 O to 25 μL for the rest):
20mM Tris-HCl pH8.820mM Tris-HCl pH8.8
10mM KCl10mM KCl
10mM(NH4)2SO4 10mM(NH 4 ) 2 SO 4
14mM MgSO4 14mM MgSO 4
0.1%Triton X-1000.1% Triton X-100
1M甜菜碱1M Betaine
1.25mM dNTP1.25mM dNTPs
8U Bst DNA聚合酶(NEW ENGLAND Biolabs)8U Bst DNA Polymerase (NEW ENGLAND Biolabs)
120μM HNB120 μM HNB
第3组引物:Group 3 primers:
1600nM SAU-MF-3(SEQ ID NO.5所示)1600nM SAU-MF-3 (shown in SEQ ID NO.5)
1600nM SAU-MR-3(SEQ ID NO.6所示)1600nM SAU-MR-3 (shown in SEQ ID NO.6)
靶核酸1:金黄色葡萄球菌阳性质控Target nucleic acid 1: Staphylococcus aureus positive quality control
靶核酸2:金黄色葡萄球菌基因组Target Nucleic Acid 2: Genome of Staphylococcus aureus
靶核酸3:志贺氏菌基因组Target nucleic acid 3: Shigella genome
靶核酸4:大肠杆菌基因组Target nucleic acid 4: Escherichia coli genome
靶核酸5:沙门氏菌基因组Target nucleic acid 5: Salmonella genome
靶核酸6:李斯特氏菌基因组Target nucleic acid 6: Listeria genome
靶核酸7:副溶血弧菌基因组Target nucleic acid 7: Vibrio parahaemolyticus genome
同时设置无靶的对照组,作为阴性对照。At the same time, a target-free control group was set up as a negative control.
每组扩增反应设置8个重复试验。设置恒温水浴锅反应温度恒定为63℃,反应时间为60min。阴阳性反应终点结果如图4所示,其中,颜色为紫罗兰表示阴性,天蓝色表示阳性。实验结果表明:使用HNB可通过颜色直观地判断反应结果,无需仪器辅助即可进行判读。Eight replicates were set up for each set of amplification reactions. Set the constant temperature water bath to keep the reaction temperature at 63°C and the reaction time at 60min. The results of negative and positive reaction endpoints are shown in Figure 4, where the color is violet for negative, and sky blue for positive. The experimental results show that: using HNB, the reaction result can be judged intuitively through the color, and the interpretation can be carried out without the aid of the instrument.
上述仅为本发明的部分优选实施例,本发明并不仅限于实施例的内容。对于本领域中的技术人员来说,在本发明技术方案的构思范围内可以有各种变化和更改,所作的任何变化和更改,均在本发明的保护范围之内。The above are only some preferred embodiments of the present invention, and the present invention is not limited to the content of the embodiments. For those skilled in the art, various changes and modifications can be made within the concept scope of the technical solution of the present invention, and any changes and modifications made are within the protection scope of the present invention.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210969466.7A CN115927674A (en) | 2022-08-12 | 2022-08-12 | CDA primer group and kit for detecting staphylococcus aureus and application of CDA primer group and kit |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210969466.7A CN115927674A (en) | 2022-08-12 | 2022-08-12 | CDA primer group and kit for detecting staphylococcus aureus and application of CDA primer group and kit |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115927674A true CN115927674A (en) | 2023-04-07 |
Family
ID=86551140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210969466.7A Pending CN115927674A (en) | 2022-08-12 | 2022-08-12 | CDA primer group and kit for detecting staphylococcus aureus and application of CDA primer group and kit |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115927674A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090305975A1 (en) * | 2006-04-17 | 2009-12-10 | Guang Yang | Use of Trap Protein Per se as an Active Ingredient for the Manufacture of a Medicament for the Treatment of Staphylococcus Aureus Infection |
| CN106434917A (en) * | 2016-09-24 | 2017-02-22 | 中华人民共和国广州机场出入境检验检疫局 | A kind of LAMP primer set, detection kit and application method of Staphylococcus aureus |
| CN113201583A (en) * | 2021-04-29 | 2021-08-03 | 中国科学院大学宁波生命与健康产业研究院 | Method for synthesizing nucleic acid under constant temperature condition, kit and application |
-
2022
- 2022-08-12 CN CN202210969466.7A patent/CN115927674A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090305975A1 (en) * | 2006-04-17 | 2009-12-10 | Guang Yang | Use of Trap Protein Per se as an Active Ingredient for the Manufacture of a Medicament for the Treatment of Staphylococcus Aureus Infection |
| CN106434917A (en) * | 2016-09-24 | 2017-02-22 | 中华人民共和国广州机场出入境检验检疫局 | A kind of LAMP primer set, detection kit and application method of Staphylococcus aureus |
| CN113201583A (en) * | 2021-04-29 | 2021-08-03 | 中国科学院大学宁波生命与健康产业研究院 | Method for synthesizing nucleic acid under constant temperature condition, kit and application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113322338B (en) | A CDA primer set, kit and application for detecting Shigella | |
| CN113416799B (en) | CDA primer group and kit for detecting African swine fever virus and application of CDA primer group and kit | |
| CN106868220A (en) | A kind of LAMP primer group and kit for expanding MERS CoV | |
| WO2021003878A1 (en) | Cpa primer and kit for detecting methicillin-resistant staphylococcus aureus, and detection method | |
| CN108359717A (en) | A kind of direct expansion RPA visualization of presence detection methods | |
| CN110551851A (en) | CAMP primer group for amplifying ASFV, kit and application | |
| CN113862393A (en) | Method for rapidly detecting cryptococcus gatherensis | |
| CN109355405B (en) | Primer, kit and method for detecting Vibrio parahaemolyticus by PSR isothermal amplification reaction | |
| CN117511935A (en) | LAMP (loop-mediated isothermal amplification) detection primer and rapid detection method for pepper anthracnose based on TUB2 | |
| CN117511934A (en) | SOD2-based primers and rapid detection method for LAMP detection of pepper anthracnose | |
| CN109355404B (en) | Primer, kit and detection method for isothermal detection of listeria monocytogenes based on polymerase helix reaction | |
| CN106086206A (en) | Green Wei Si Salmonella loop-mediated isothermal gene amplification fast detecting kit and detection method | |
| CN110863061A (en) | Specific LAMP primers, kits and methods for detecting Staphylococcus aureus | |
| CN114277170B (en) | A primer and kit for multiplex PCR detection of nine kinds of foodborne pathogenic bacteria | |
| CN115927674A (en) | CDA primer group and kit for detecting staphylococcus aureus and application of CDA primer group and kit | |
| CN111004854B (en) | Rapid constant temperature detection method, primer set and kit for vibrio vulnificus and vibrio cholerae simultaneously | |
| CN115094154A (en) | A LAMP primer composition, kit and detection method for detecting heterobasidiomycetes of Araucaria chinensis | |
| CN115927675A (en) | CDA primer group and kit for detecting salmonella and application of CDA primer group and kit | |
| CN110564822B (en) | LAMP technology-based transgenic corn Bt 176-related gene detection method and kit | |
| CN106755411A (en) | The real-time fluorescence quantitative PCR quick detection primer and its kit of marine product vibrio parahemolyticus toxR genes | |
| CN116004862A (en) | CDA primer set and kit for detecting klebsiella pneumoniae and application of CDA primer set and kit | |
| CN116790770A (en) | CDA primer set and kit for detecting mycobacterium tuberculosis and application of CDA primer set and kit | |
| CN104928287B (en) | One group of nucleotide sequence and the application in Aeromonas hydrophila is identified | |
| CN114381554A (en) | A CDA primer pair, kit and application for detecting porcine circovirus type II | |
| CN114164296B (en) | A primer probe composition, kit, application and detection method for detecting Pythium oligandrum |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20230407 |